Checchi Capital Advisers LLC Sells 549 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Checchi Capital Advisers LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 17.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,516 shares of the company’s stock after selling 549 shares during the period. Checchi Capital Advisers LLC’s holdings in HCA Healthcare were worth $755,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Legacy Investment Solutions LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth $39,000. Capital Performance Advisors LLP purchased a new stake in HCA Healthcare in the 3rd quarter worth $41,000. Activest Wealth Management lifted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. lifted its stake in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Finally, Eastern Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at about $62,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $319.65 on Thursday. The firm has a market cap of $79.38 billion, a price-to-earnings ratio of 14.55, a PEG ratio of 1.10 and a beta of 1.64. The company’s 50 day moving average is $314.65 and its 200 day moving average is $350.12. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business earned $5.90 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is currently 13.11%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HCA. Truist Financial decreased their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Finally, Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.